Daniel Woolson - 15 Mar 2026 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: VP, GM-Infusion Capital
Signature: By: Paula Darbyshire, Attorney-in-Fact For: Daniel Woolson
Issuer symbol: ICUI
Transactions as of: 15 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 16 Mar 2026, 16:33:55 UTC
Previous filing: 09 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Woolson Daniel	VP, GM-Infusion Capital	951 CALLE AMANECER, SAN CLEMENTE	By: Paula Darbyshire, Attorney-in-Fact For: Daniel Woolson	16 Mar 2026	0001698998

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise		+2,924	+13%	$0.000000^*	25,897	15 Mar 2026	Direct	F1
transaction	ICUI	Common Stock	Tax liability		-1,295	-5%	$125.85^*	24,602	15 Mar 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Performance Shares	Options Exercise		-2,924	-100%	$0.000000^*	0	15 Mar 2026	Common Stock	2,924	$0.000000	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These Securities are Performance-based Restricted Stock Units (PRSU).
F2	There is neither a purchase price nor an exercise price for the PRSUs.
F3	These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant.